Cargando…
Evaluation of the use of therapeutic peptides for cancer treatment
Cancer along with cardiovascular disease are the main causes of death in the industrialised countries around the World. Conventional cancer treatments are losing their therapeutic uses due to drug resistance, lack of tumour selectivity and solubility and as such there is a need to develop new therap...
Autores principales: | Marqus, Susan, Pirogova, Elena, Piva, Terrence J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359827/ https://www.ncbi.nlm.nih.gov/pubmed/28320393 http://dx.doi.org/10.1186/s12929-017-0328-x |
Ejemplares similares
-
Bioactive peptide design using the Resonant Recognition Model
por: Cosic, Irena, et al.
Publicado: (2007) -
Enhancing Peptide Biomaterials for Biofabrication
por: Firipis, Kate, et al.
Publicado: (2021) -
The Pathophysiology and the Therapeutic Potential of Cannabinoids in Prostate Cancer
por: Singh, Kanika, et al.
Publicado: (2021) -
Biological Effects of a De Novo Designed Myxoma Virus Peptide Analogue: Evaluation of Cytotoxicity on Tumor Cells
por: Istivan, Taghrid S., et al.
Publicado: (2011) -
A bioactive peptide analogue for myxoma virus protein with a targeted cytotoxicity for human skin cancer in vitro
por: Almansour, Nahlah M, et al.
Publicado: (2012)